期刊文献+

Inhibitory effects of copper-aspirin complex on platelet aggregation 被引量:2

Inhibitory effects of copper aspirin complex on platelet aggregation
原文传递
导出
摘要 目的:研究阿司匹林铜(CuAsp)对血小板聚集性的影响及其机制.方法:用Born氏法测定CuAsp对兔血小板聚集性的影响.用荧光光度法和放射免疫法观察CuAsp对兔血小板5羟色胺的释放和TXB2的产生及血浆中TXB2和6ketoPGF1α水平的影响.结果:CuAsp体外呈浓度依赖性抑制花生四烯酸(AA)诱导的血小板聚集和5羟色胺的释放(IC50分别为17和19μmol·L-1,95%可信限为9-33和10-30μmol·L-1),且抑制TXB2的产生(P<005).CuAsp10mg·kg-1灌胃选择性抑制AA诱导聚集.降低血浆TXB2,同时升高6ketoPGF1α的水平(P<005).结论:CuAsp体内外均有比Asp更强的抗血小板聚集作用. IM: To study the inhibitory effects of copper aspirin complex (CuAsp) on platelet aggregation. METHODS: With adenosine diphosphate the effects of CuAsp on platelet aggregation in vitro or in vivo were investigated. Radioimmunoassay and fluoro ̄photometry were used to measure throm ̄box ̄ane B 2 (TXB 2) generation from platelets, the levels of TXB 2 and of 6 keto PGF 1α in plasma and the platelet serotonin release reaction. RESULTS: In vitro , CuAsp inhibited arachidonic acid (AA) induced aggregation (IC 50 =17 μmol·L -1 , 95 % confidence limits: 9-33 μmol·L -1 ), the release of 5 HT (IC 50 =19 μmol·L -1 , 95 % confidence limits: 10-30 μmol·L -1 ), and TXB 2 generation from platelets ( P <0 05). CuAsp 10 mg·kg -1 ig selectively inhibited AA induced aggregation, and increased the 6 keto PGF 1α concentration in plasma while decreased that of TXB 2. CONCLUSION: CuAsp, in vitro or in vivo , shows more potent inhibitory effects on AA induced aggregation than aspirin (Asp), related to the inhibition of platelet cyclooxygenase and the release of active substances from platelets.
出处 《中国药理学报》 CSCD 1997年第4期358-362,共5页 Acta Pharmacologica Sinica
关键词 阿司匹林 血小板聚集 copper aspirin platelet aggregtion thromboxane A 2 epoprostenol serotonin arachidonic acid adenosine diphosphate platelet activating factor
  • 相关文献

参考文献3

  • 1Shi Y Q,中国医学科学院学报,1986年,8卷,310页
  • 2Wang Z,中国医学科学院学报,1986年,8卷,139页
  • 3Wan H Y,江苏医药,1985年,11卷,24页

同被引文献22

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部